App-Quantinova.ai

Erythrocyte Rigidity Affects Blood Clot Contraction and Formation of Polyhedrocytes

Rustem I. Litvinov - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Patterns of Enoxaparin Use for Venous Thromboembolism Prevention in a Pediatric Center

Arash Mahajerin - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Enoxaparin

Are Direct Oral Anticoagulants Plasma Concentrations Associated with the Risk of Postoperative Bleeding? Results from the Real Life Cohort

Pavel Olivera - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

rivaroxaban

The Safety and Efficacy of Full Versus Reduced Dose Betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention with Extended Duration Betrixaban (APEX) Trial

Alexander T Cohen - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

betrixaban

Incidence and Outcomes of Catheter Related Thrombosis in Acute Leukemia: Single Centre Experience

Mabel Ma - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Thrombosis in Hodgkin Lymphoma Patients: Incidence, Time Points, Risk Factors and Impact of Stage and Treatment

Sven Borchmann - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

The Impact of Myeloproliferative Neoplasms (MPNs) on Patients' Quality of Life and Productivity: Results from the International MPN Landmark Survey

Claire N. Harrison - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Major Bleeding Complications Among Patients Treated with Ibrutinib and Concomitant Antiplatelet, Anticoagulant, or Supplemental Therapy

Aaron Pavlik - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Ibrutinib

Risk of Venous Thromboembolism in Multiple Myeloma: Identification of Risk Factor

Kristen M. Sanfilippo - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Aspirin

Risk Stratification for the Development of Venous Thromboembolism in Hospitalized Patients with Cancer

Arabesque Parker - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Age-Adjusted D-Dimer Cut-Off Levels to Rule-out Venous Thromboembolism in Patients with Non-High Pre-Test Probability. Clinical Performance and Cost-Effectiveness Analysis

Pierre A. Toulon - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Venous Thromboembolism in Pediatric Heart Disease Is Associated with Significant Health Care Burden and Expenditures

Gary Woods - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Healthcare Resource Utilization and Costs Associated with Venous Thromboembolism Recurrence in Patients with Cancer

Alok A. Khorana - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Evaluating the Effects of an Evidence-Based Hemostasis and Thrombosis Treatment Algorithm Tool on Medical Practitioner and Trainee Clinical Decision Making

Joseph Shatzel - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Hemostatic Solution

Morbidity, Mortality and Costs Associated with Venous Thromboembolism in Hospitalized Patients with Cancer

Gary H. Lyman - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Risk of Venous Thromboembolism in Hospitalized Patients with Sickle Cell Disease

Alexandra Anghel - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

THE NATURAL HISTORY OF THROMBOTIC EVENTS IN SYSTEMIC LUPUS ERYTHEMATOSUS AND ASSOCIATED RISK FACTORS

K. Hickman - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

FREQUENCY AND PREDICTIVE VARIABLES OF RELAPSES IN PATIENTS WITH BIOPSY-PROVEN GIANT CELL ARTERITIS

G. Restuccia - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Glucocorticoid

NOACS: NOVEL ORAL ANTICOAGULANTS NEW OPPORTUNITIES IN RHEUMATOLOGY?

H. Cohen - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Venous thrombosis

rivaroxaban

NEW DEVELOPMENTS IN ANTIPHOSPHOLIPID SYNDROME

D. -Cruz - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Filters

7277 Abstracts